captopril has been researched along with s-nitroso-n-acetylpenicillamine in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (37.50) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| De la Lande, IS; Horowitz, JD; Stafford, I; Zhang, CL | 1 |
| Craven, PA; DeRubertis, FR; Felder, J; Phillips, S; Studer, RK | 1 |
| Andersson, RG; Persson, K | 1 |
| Andersson, RG; Glindell, M; Jacobsson-Strier, M; Nyhlén, K; Persson, K; Whiss, PA | 1 |
| Dasgupta, T; McGrowder, D; Ragoobirsingh, D | 1 |
| Aquart, DV; Dasgupta, TP | 1 |
| Chuang, LY; Guh, JY; Huang, JS; Hwang, JY; Kan, WC; Liu, YB; Yang, YL | 1 |
8 other study(ies) available for captopril and s-nitroso-n-acetylpenicillamine
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
S-nitrosothiol modulation of tolerance to glyceryl trinitrate in bovine isolated coronary artery.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Captopril; Cattle; Coronary Vessels; Dose-Response Relationship, Drug; Drug Tolerance; In Vitro Techniques; Nitroglycerin; Nitroso Compounds; Penicillamine; Prostaglandin Endoperoxides, Synthetic; S-Nitroso-N-Acetylpenicillamine; Thromboxane A2; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents | 1994 |
Nitric oxide inhibition of transforming growth factor-beta and collagen synthesis in mesangial cells.
Topics: Animals; Captopril; Cattle; Cells, Cultured; Coculture Techniques; Collagen; Cyclic GMP; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme Inhibitors; Glomerular Mesangium; Glucose; Indoles; Maleimides; Nitric Oxide; omega-N-Methylarginine; Osmolar Concentration; Penicillamine; Proline; Protein Kinase C; RNA, Messenger; S-Nitroso-N-Acetylpenicillamine; Time Factors; Transforming Growth Factor beta; Tritium | 1997 |
Nitric oxide modulates captopril-mediated angiotensin-converting enzyme inhibition in porcine iliac arteries.
Topics: 3-Mercaptopropionic Acid; Angiotensin I; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Captopril; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme Inhibitors; Iliac Artery; In Vitro Techniques; Nitric Oxide; Nitric Oxide Donors; Nitroarginine; Penicillamine; Peptidyl-Dipeptidase A; S-Nitroso-N-Acetylpenicillamine; Swine; Vasoconstriction; Vasodilation | 1999 |
Nitric oxide donors and angiotensin-converting enzyme inhibitors act in concert to inhibit human angiotensin-converting enzyme activity and platelet aggregation in vitro.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Cells, Cultured; Dose-Response Relationship, Drug; Drug Synergism; Enalaprilat; Endothelium, Vascular; Female; Humans; Molsidomine; Nitric Oxide Donors; Penicillamine; Peptidyl-Dipeptidase A; Platelet Aggregation; S-Nitroso-N-Acetylpenicillamine; Umbilical Veins | 2000 |
Decreased insulin binding to mononuclear leucocytes and erythrocytes from dogs after S-nitroso-N-acetypenicillamine administration.
Topics: Animals; Binding, Competitive; Captopril; Cell Membrane; Dogs; Erythrocytes; Female; Insulin; Kinetics; Leukocytes, Mononuclear; Male; Nitric Oxide Donors; Receptor, Insulin; S-Nitroso-N-Acetylpenicillamine | 2002 |
The reaction of S-nitroso-N-acetyl-D,L-penicillamine (SNAP) with the angiotensin converting enzyme inhibitor, captopril--mechanism of transnitrosation.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Hydrogen-Ion Concentration; Nitrosation; S-Nitroso-N-Acetylpenicillamine; Spectrum Analysis | 2005 |
Angiotensin-converting enzyme inhibitors attenuated advanced glycation end products-induced renal tubular hypertrophy via enhancing nitric oxide signaling.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Cell Enlargement; Cell Line; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Enalapril; Enzyme Activation; Glycation End Products, Advanced; Humans; Hypertrophy; Kidney Tubules, Proximal; MAP Kinase Signaling System; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase Type II; S-Nitroso-N-Acetylpenicillamine; Signal Transduction; Thionucleotides | 2019 |